Key Takeaways Veeva launched Veeva AI to automate tasks and streamline decisions across its core Vault platform. By embedding GenAI in Vault, Veeva aims to boost productivity in clinical and regulatory operations. VEEV shares are up 34.6% YTD, outpacing the industry's 22.5% gain.Veeva Systems (VEEV) is expanding its capabilities by introducing Veeva AI, a generative AI layer built into its core Vault platform. This development enables life sciences companies to automate routine tasks, such as document cre ...

The Nasdaq is in a new bull market. But recently soaring technology stocks are likely due for a cooldown and a pullback following the massive rally off the April lows.Despite the rally, plenty of strong technology stocks are trading miles below their peaks for various reasons.Investors might want to buy some of these best-in-class, beaten-down tech stocks before everyone else on Wall Street starts searching for deals again.Buy This AI Chip Stock Down 50% Before Earnings?Data infrastructure semiconductor sol ...

Core Insights - Veeva Systems has launched Veeva AI, an initiative to integrate AI into the Veeva Vault Platform and applications, aimed at automating industry-specific functions and enhancing productivity across various sectors from clinical to commercial [1][5] - Veeva AI utilizes large language models (LLMs) to create application-specific AI Agents and AI Shortcuts, enabling life sciences companies to streamline tasks and improve employee efficiency [1][2] Veeva AI Features - Veeva AI Agents can be quickly deployed with high impact due to their understanding of Veeva application context, application-specific prompts, and secure access to application data and workflows [2] - Customers have the flexibility to configure Veeva-delivered AI Agents or develop custom AI Agents tailored to specific use cases, accessible via a chatbot interface or AI API [2] User Empowerment - Veeva AI Shortcuts allow end users to set up personal AI-powered automations for frequent tasks, such as workflow assistance, generating insights, or conducting research [3] Strategic Vision - Veeva's CEO, Peter Gassner, emphasized that the integration of GenAI with core applications will significantly enhance productivity for knowledge workers by providing human-like capabilities to derive insights from complex data [4] - Veeva AI is designed to be LLM agnostic, supporting various major LLMs, and ensuring customer data security regardless of the LLM used [4] Market Positioning - The first release of Veeva AI is scheduled for December 2025, with a subscription model aimed at promoting broad and thoughtful industry adoption [5] - Veeva serves over 1,000 customers in the life sciences sector, including major biopharmaceutical companies and emerging biotechs, highlighting its leadership in cloud software solutions [6]